Regenerative Bio is a longevity company driven by artificial intelligence. Founded in 2021 with the vision of "Health Equity - Empowering Everyone to Age Gracefully and Healthily", the company has developed "Organ-level aging clock" technology and applied it into their platform RevOrgan through precise measurements and effective intervertions solutions. Regenerative Bio’s team consisted of world-class scientists and top-level business operation talents. Its Scientific Advisory Board includes renowned professors Dr. George Church, Dr. Vadim Gladyshev and Dr. Tian Xu. The company has raised over $10 million in Angel Round and A Round, backed up by investors including IMO Ventures, 5Y Capital, K2VC, Uphonest Capital, Taihill Venture and Yael Capital.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 245 Main St, Cambridge,massachusetts,united States
- Industry
- Biotechnology
- Website
- https://regen-bio.us/
- Keywords
- Cambridge.
- HQ
- Cambridge, Massachusetts
Regenerative Bio Inc. Questions
Regenerative Bio Inc.'s website is https://regen-bio.us/
Regenerative Bio Inc.'s LinkedIn profile is https://www.linkedin.com/company/regenerativebio
Regenerative Bio Inc. has
13 employees.
View email and phone details for 13
employees at Regenerative Bio Inc..
Regenerative Bio Inc.'s industry is
Biotechnology
Regenerative Bio Inc.'s top competitors are
Cars Universal Inc.,
Taihill Venture,
Gqg Partners,
Laife,
燃石医学 Burning Rock Biotech,
Inner City Law Center,
Replimune,
Kula Bio,
Kajiken Usa,
Dnanexus.
Regenerative Bio Inc.'s categories are Biotechnology
Regenerative Bio Inc.'s founding year is 2021
